Healthcare Stocks Generating Over 100% Annual Return to Shareholders

Wall St. Watchdog shares information on companies in the Healthcare sector whose stocks have doubled over the past year.  All companies have a market capitalization of at least $1 billion.

  • Amarin Corporation plc (NASDAQ:AMRN): This company’s stock has increased by 552.78% over the past 52 weeks. The stock recently traded at $14.10 and its market capitalization is $1,829,676,000. About the company:  Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.
  • Pharmasset, Inc. (NASDAQ:VRUS): This company’s stock has increased by 398.81% over the past 52 weeks. The stock recently traded at $134.28 and its market capitalization is $4,993,080,000. About the company:  Pharmasset, Inc. is a pharmaceutical company. The Company develops oral therapeutics for the human immunodeficiency virus, hepatitis B, and hepatitis C.
  • Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ): This company’s stock has increased by 328.88% over the past 52 weeks. The stock recently traded at $37.57 and its market capitalization is $1,530,670,000. About the company:  Jazz Pharmaceuticals, Inc. develops and markets treatments for neurological and psychiatric conditions. The Company produces treatments for cataplexy, excessive daytime sleepiness, and ethylene glycol and methanol poisoning in humans.
  • Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): This company’s stock has increased by 292.52% over the past 52 weeks. The stock recently traded at $12.60 and its market capitalization is $1,663,124,000. About the company:  ARIAD Pharmaceuticals, Inc. discovers, develops, and commercializes small-molecule drugs to treat aggressive cancers. The Company’s first product candidate is an investigational mTOR inhibitor. ARIAD’s second product candidate is an investigational pan BCR-ABL inhibitor for treatment of blood cancers.
  • InterMune, Inc. (NASDAQ:ITMN): This company’s stock has increased by 236.17% over the past 52 weeks. The stock recently traded at $35.97 and its market capitalization is $2,128,953,000. About the company:  InterMune, Inc. is a biopharmaceutical company. The Company develops therapies for hepatology and pulmonology, including treatments for severe, malignant osteopetrosis and chronic granulomatous disease
  • Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR): This company’s stock has increased by 193.78% over the past 52 weeks. The stock recently traded at $26.91 and its market capitalization is $1,659,682,000. About the company:  Questcor Pharmaceuticals, Inc. develops and commercializes novel central nervous system-focused therapeutics that address significant unmet medical needs. The Company’s primary product is a natural source adrenocorticotropic hormone indicated for the treatment of acute exacerbations of multiple sclerosis, as well as a number of other conditions.
  • MAKO Surgical Corp. (NASDAQ:MAKO): This company’s stock has increased by 168.22% over the past 52 weeks. The stock recently traded at $31.73 and its market capitalization is $1,299,643,000. About the company:  MAKO Surgical Corp. is a medical device company. The Company offers robotic-ARM solutions and implants for minimally invasive orthopedic knee procedures.
  • Valeant Pharmaceuticals Int (NYSE:VRX): This company’s stock has increased by 162.21% over the past 52 weeks. The stock recently traded at $55.85 and its market capitalization is $16,474,510,000. About the company:  Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders; and distributes generic and branded generic drugs in Latin America and Eastern Europe.
  • Elan Corporation, plc (NYSE:ELN): This company’s stock has increased by 156.37% over the past 52 weeks. The stock recently traded at $12.28 and its market capitalization is $7,413,373,000. About the company:  Elan Corporation plc is a specialty pharmaceutical company. The Group’s drug delivery technologies are designed to aid and control the absorption and utilization of active pharmaceutical compounds. Elan’s Pharmaceutical division focuses on the discovery, development and commercialization of products in the areas of acute care, pain management, infectious diseases and neurology.
  • Exelixis, Inc. (NASDAQ:EXEL): This company’s stock has increased by 151.40% over the past 52 weeks. The stock recently traded at $8.07 and its market capitalization is $1,031,630,000. About the company:  Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
  • ZOLL Medical Corporation (NASDAQ:ZOLL): This company’s stock has increased by 136.58% over the past 52 weeks. The stock recently traded at $58.53 and its market capitalization is $1,282,641,000. About the company:  Zoll Medical Corporation designs, manufactures, and markets an integrated line of proprietary, non-invasive resuscitation devices and disposable electrodes. The Company’s products are used by health care professionals to provide pacing and defibrillation. Zoll also designs and markets software that automates collection and management of data for emergency medical service providers.
  • Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): This company’s stock has increased by 131.78% over the past 52 weeks. The stock recently traded at $55.65 and its market capitalization is $5,058,092,000. About the company:  Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
  • AMERIGROUP Corporation (NYSE:AGP): This company’s stock has increased by 125.33% over the past 52 weeks. The stock recently traded at $71.43 and its market capitalization is $3,543,144,000. About the company:  AMERIGROUP Corporation, a multi-state managed healthcare company, serves people who receive healthcare benefits through state-sponsored programs. Programs include Medicaid, Children’s Health Insurance Program, and Family Care. The Company provides managed care and medical management programs, as well as offers community-based education and outreach programs.
  • Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN): This company’s stock has increased by 118.71% over the past 52 weeks. The stock recently traded at $57.74 and its market capitalization is $10,614,650,000. About the company:  Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
  • The Cooper Companies, Inc. (NYSE:COO): This company’s stock has increased by 102.84% over the past 52 weeks. The stock recently traded at $79.25 and its market capitalization is $3,719,436,000. About the company:  The Cooper Companies, Inc. through its subsidiaries, develops, manufactures, and markets specialty healthcare products. The Company’s products include contact lenses for the vision care market and diagnostic products, surgical instruments, and accessories for gynecologists and obstetricians.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>